Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans
about
sameAs
Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic reviewGaseous mediators nitric oxide and hydrogen sulfide in the mechanism of gastrointestinal integrity, protection and ulcer healingNitric oxide-modulating agents for gastrointestinal disordersPharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disordersTherapeutic effects of nitric oxide-aspirin hybrid drugsMechanism of action of novel NO-releasing furoxan derivatives of aspirin in human plateletsEffect of opium addiction on aspirin resistance in stable angina pectoris.The PIT: SToPP Trial-A Feasibility Randomised Controlled Trial of Home-Based Physiotherapy for People with Parkinson's Disease Using Video-Based Measures to Preserve Assessor BlindingRecent developments in nitric oxide donor drugs.Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential.Novel therapies targeting vascular endothelium.Role of nitric oxide in the gastrointestinal tractBile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa.Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety.Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia.The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.
P2860
Q21090146-6FC6D486-9C87-40CC-884E-31EB58492468Q28083755-ADE65B28-5C73-435A-8481-9B9C571545F6Q28192955-F8A4FBE7-B271-4E2C-A1ED-A482C867C411Q28200449-6D3776F6-B2E6-455E-A448-9E1F8966B8ECQ28210282-DB9D1768-D788-4FA8-85D1-1F915F395516Q28218042-67AA11D7-4183-4EE0-9E60-D34D012626ABQ34063900-D42B642F-2969-48C4-A5D2-965E69BB6367Q35419872-1683A863-D7D2-43A1-A17B-8E5BE3030595Q36052815-CA5799A9-8506-4C63-85F6-B6BDB6894CD9Q36196462-D2729E66-EEFB-41E8-9651-544765B21A4BQ36684472-0C9FAED8-7636-46AF-89E5-81B9F0B30381Q36972486-AFCF9E18-2C61-429B-9370-2EF71B33A2DDQ38364542-0816E9DF-2135-4E1A-9660-4AEE425B3846Q38558587-B9746261-79D2-41E2-B806-D6FC1EF4D589Q42667008-104B8D0E-33D9-4ABE-89C3-4C427CC66241Q49346285-540FCE6C-AA05-4694-B6F2-C1A83C24EE8D
P2860
Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Co-administration of nitric ox ...... e induced by aspirin in humans
@ast
Co-administration of nitric ox ...... e induced by aspirin in humans
@en
Co-administration of nitric ox ...... e induced by aspirin in humans
@nl
type
label
Co-administration of nitric ox ...... e induced by aspirin in humans
@ast
Co-administration of nitric ox ...... e induced by aspirin in humans
@en
Co-administration of nitric ox ...... e induced by aspirin in humans
@nl
prefLabel
Co-administration of nitric ox ...... e induced by aspirin in humans
@ast
Co-administration of nitric ox ...... e induced by aspirin in humans
@en
Co-administration of nitric ox ...... e induced by aspirin in humans
@nl
P2093
P1476
Co-administration of nitric ox ...... e induced by aspirin in humans
@en
P2093
Alessandra Meneguzzi
Alessandro Lechi
Andrea Mencarelli
Antonio Morelli
Barbara Renga
Piero del Soldato
Pietro Minuz
P304
P356
10.1016/J.JACC.2004.03.079
P407
P577
2004-08-04T00:00:00Z